Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Email

2023 International Papillomavirus Conference

April 17 – April 21, 2023

Walter E. Washington Convention Center Washington, DC

Add to Outlook Calendar

IPVC 2023, April 17-21, Washington, DC, In-person and online

Several DCEG scientists will present their research at the 2023 International Papillomavirus Conference (IPVC) in Washington, DC and online from April 17-21. The full program can be found on the IPVC website

Monday, April 17

Chaired Sessions

ChairSessionTime
Sarah S. JacksonSpecial Interest Satellite Symposium: HPV among transgender and gender diverse individuals: understanding the unique needs of the population8:30 - 10:00 AM EDT
Aimee R. KreimerPublic Health Workshop 01: HPV vaccination for prevention of cervical cancer1:30 - 3:00 PM EDT
Nicolas WentzensenPublic Health Workshop 02: Cervical Cancer Screening2:30 - 5:00 PM EDT

Oral Presentations

PresenterSessionPresentation TitleTime
Julia C. GageSpecial Interest Satellite Symposium: Cervical Cancer Control in Latin America and the Caribbean A facilitation strategy for rapid, embedded engagement in HPV-based screening implementation planning in low- and middle-income countries (LMICs)11:45 AM EDT
Megan ClarkeClinical Workshop 01New technologies for screening in developed and developing country settings1:30 - 1:50 PM EDT
Jaimie Z. ShingPublic Health Workshop 01HPV vaccination to prevent invasive cervical cancer2:04 - 2:22 PM EDT
Anil ChaturvediClinical Workshop 02Current epidemiology of head and neck cancer3:45 - 4:00 PM EDT
Nicolas WentzensenPublic Health Workshop 02Overview of epidemiologic methods: Sensitivity, specificity, predictive value, and risk-based triaging4:15 - 4:30 PM EDT

Tuesday, April 18

Chaired Sessions

ChairSessionTime
John T. SchillerClinical Workshop 04: New frontier in treatment of HPV-related cancers and pre-cancers8:30 - 10:00 AM EDT
 
Lisa MirabelloBasic Science Workshop 04: HPV genomics and evolution10:30 AM - 12:00 PM EDT
 

Oral Presentations

PresenterSessionPresentation TitleTime
Aimee R. KreimerClinical Workshop 03HPV vaccine schedules - Latest updates9:00 - 9:15 AM EDT
Lisa MirabelloBasic Science Workshop 04HPV genetic diversity, APOBEC mutagenesis11:30 AM - 12:00 PM EDT
John T. SchillerClinical Workshop 04Can we and should we treat HPV infection?11:30 AM - 12:00 PM EDT
Meredith ShielsPublic Health Workshop 05Evidence of inequity: Incidence and burden of cervical and other HPV-related cancers by ethnicity and race.2:00 - 2:15 PM EDT
Sarah S. JacksonPublic Health Workshop 05HPV vaccination, cancer prevention, and its associated challenges in SGM.3:00 - 3:15 PM EDT

Wednesday, April 19

Panels

PanelistSessionTime
Jaimie Z. ShingEarly Career Researchers Session 2: Publish or perish: The future of academic publishing7:00 - 8:00 AM EDT

Chaired Sessions

ChairSessionTime
Jaimie Z. ShingPublic Health Oral: Vaccination 19:45 - 10:45 AM EDT
Aimee R. KreimerSpecial Interest Satellite Symposium: Current evidence for safety profile of the HPV Vaccines5:15 - 6:45 PM EDT

Oral Presentation

PresenterSessionPresentation TitleTime
Nicolas WentzensenSpecial Interest Satellite Symposium: New guidelines for validation of HPV assays usable in cervical cancer screeningFDA principles for validation of HPV assays in the USA10:21 - 10:33 AM EDT
Jaimie Z. ShingPublic Health Oral: Vaccination 3Differential HPV 16/18 vaccine efficacy against HPV13 by variants in the L1 sequence up to 11-years post-vaccination in the Costa Rica HPV Vaccine Trial4:35 - 4:45 PM EDT
Nicolas WentzensenClinical Science OralClinical performance of dual stain vs. cytology combined with extended genotyping in a large population of HPV-positive individuals: Implications for cervical cancer screening strategies6:35 - 6:45 PM EDT

Poster Discussion

PresenterSessionPresentation TitleTime
Cameron B. HaasPublic Health 02Anal test characteristics and disease detection among healthy women referred to high-resolution anoscopy: Findings from the Costa Rica Vaccine Trial Study9:15 - 9:20 AM EDT

Meet the Poster Presenter

PresenterPresentation TitleTime
Aimee KoestlerWhole-genome sequencing of 860 HPV45 cases and controls identifies genetic variants specifically associated with cervical glandular lesions 4:45 - 5:15 PM EDT
Summer HarveyAssociations of obesity with cervical cancer screening in the National Health Interview Survey.4:45 - 5:15 PM EDT
Cameron B. HaasAnal test characteristics and disease detection among healthy women referred to high-resolution anoscopy: Findings from the Costa Rica Vaccine Trial Study5:45 - 5:15 PM EDT

Thursday, April 20

Chaired Sessions

ChairSessionTime
Lisa MirabelloClinical Science Oral: Biomarkers for management of cervical lesions with an emphasis on methylation10:30 AM - 12:00 PM EDT

Oral Presentation

PresenterSessionPresentation TitleTime
Chase W. NelsonBasic Science OralHPV16 genomics: The untold story of sublineage differences and carcinogenicity 3:00 - 3:10 PM EDT
Lisa MirabelloBasic Science OralHPV16 episomal multimers can form double-minute chromosomal structures and contribute to chromosome rearrangements 3:30 - 3:40 PM EDT
Isabel RodriguezBasic Science OralA panel of 22 cervical cancer cell lines characterized by long-read DNA and RNA sequencing: Insights into HPV integration and transcription3:50 - 4:00 PM EDT

Poster Discussion

PresenterSessionPresentation TitleTime
Erica StephensPublic Health 03Differences in HPV knowledge by race/ethnicity and educational attainment in the United States, Health Information National Trends Survey, 2016-20202:00 - 2:05 PM EDT


Friday, April 21

Oral Presentations

PresenterSessionPresentation TitleTime
Loretto J. CarvajalPublic Health OralTrends in incidence rates of head and neck squamous cell carcinomas in Costa Rica, with a special focus on human papillomavirus-related and-unrelated cancers8:50 - 9:00 AM EDT
Cameron B. HaasPublic Health OralRisk factors for anal high-grade squamous intraepithelial lesions among healthy women: Findings from the Costa Rica HPV Vaccine Trial Study9:00 - 9:10 AM EDT
Jose A. JeronimoClinical Science OralComparison of accuracy and reproducibility of colposcopic impression based on a single image versus a two-minute time series of colposcopic images 9:10 - 9:20 AM EDT
Camryn M. CohenPublic Health OralRacial and ethnic differences in cervical cancer incidence, survival and mortality by histologic subtype reveal profound disparities 2:15 - 2:25 PM EDT

Meet the Poster Presenter

PresenterPresentation TitleTime
Jaimie Z. ShingThe incidence of HPV-associated cancers among disaggregated Asian American and Pacific Islander ethnographic regions and ethnicities: A population-based study in the United States9:30 - 10:00 AM EDT
Jennifer McGee-AvillaMultilevel determinants of Pap test receipt in women living with HIV: Individual, clinical, and healthcare level patterns of cervical cancer prevention modalities9:30 - 10:00 AM EDT
Sambit K. MishraA longitudinal study of high-risk-HPV genomes reveals intra-host temporal changes to viral single nucleotide variants9:30 - 10:00 AM EDT
Erica StephensDifferences in HPV knowledge by race/ethnicity and educational attainment in the United States, Health Information National Trends Survey, 2016-20209:30 - 10:00 AM EDT

Keynote Lecture

PresenterPresentation TitleTime
Douglas LowyThe future is now4:00 - 5:30 PM EDT
Email